Pain Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. (MorphoCOPD1b)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03102970|
Recruitment Status : Completed
First Posted : April 6, 2017
Last Update Posted : June 6, 2018
The prevalence of chronic obstructive pulmonary disease (COPD) is between 8 and 12% of the adult population. This prevalence is expected to increase over the coming decades due to the aging of the population and the continued exposure to risk factors for the disease. The evolution of COPD is marked by the occurrence of exacerbations of varying severity and patients are frequently admitted to the emergency department for evaluation, treatment and / or hospitalization. Admission in emergency department for COPD exacerbation represents approximately 1% of emergency admission.
Chronic pain is common in patients with Chronic Obstructive Pulmonary Disease (COPD). The pain intensity may increase during acute episodes of exacerbations. This study is aimed to compare pain intensity during exacerbation and stable phase of patients with chronic obstructive pulmonary disease (COPD).
|Condition or disease|
|Chronic Obstructive Pulmonary Disease|
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Morpho-COPD1b : Pain Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.|
|Actual Study Start Date :||December 2015|
|Actual Primary Completion Date :||April 5, 2018|
|Actual Study Completion Date :||April 5, 2018|
- Variation of the short-form McGill Pain Questionnaire (SF-MPQ) between the exacerbation and the stable phase at 30 days [ Time Frame: 30 days after exacerbation ]McGill Pain Questionnaire (SF-MPQ)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03102970
|Emergency department of Hôpital du Sacré Coeur de Montréal|
|Emergency Department of university hospital|
|Grenoble, France, 38043|
|Principal Investigator:||Maxime MAIGNAN||University Hospital, Grenoble|